• 1
    Shore RE, Woodard ED, Pasternack BS, et al. Radiation and host factors in human thyroid tumors following thymus irradiation. Health Phys 1980; 38: 45165.
  • 2
    United Nations Scientific Committee on the Effects of Atomic Radiation, Effects of Ionizing Radiation. UNSCEAR 2006 Report, Volume 1. United Nations, 2008.
  • 3
    Imaizumi M, Usa T, Tominaga T, et al. Radiation dose-response relationships for thyroid nodules and autoimmune thyroid diseases in Hiroshima and Nagasaki atomic bomb survivors 55-58 years after radiation exposure. JAMA 2006; 295: 101122.
  • 4
    Preston DL, Ron E, Tokuoka S, et al. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 2007; 168: 164.
  • 5
    Ron E, Lubin JH, Shore RE, et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 1995; 141: 25977.
  • 6
    Ron E, Schneider AB. Thyroid cancer. In: Schottenfeld D, Fraumeni JF. Cancer epidemiology and prevention, 3rd edn. New York: Oxford University Press, 2006.
  • 7
    Dickman PW, Holm LE, Lundell G, et al. Thyroid cancer risk after thyroid examination with 131I: a population-based cohort study in Sweden. Int J Cancer 2003; 106: 5807.
  • 8
    Sadetzki S, Chetrit A, Lubina A, et al. Risk of thyroid cancer after childhood exposure to ionizing radiation for tinea capitis. J Clin Endocrinol Metab 2006; 91: 4798804.
  • 9
    Adams MJ, Shore RE, Dozier A, et al. Thyroid cancer risk 40+ years after irradiation for an enlarged thymus: an update of the Hempelmann cohort. Radiat Res 2010; 174: 75362.
  • 10
    Ozasa K, Shimizu Y, Suyama A, et al. Studies of the mortality of atomic bomb survivors, report 14, 1950–2003: An overview of cancer and noncancer diseases. Radiat Res 2012; 177: 22943.
  • 11
    Hayashi Y, Lagarde F, Tsuda N, et al. Papillary microcarcinoma of the thyroid among atomic bomb survivors: tumor characteristics and radiation risk. Cancer 2010; 116: 164655.
  • 12
    Cullings HM, Fujita S, Funamoto S, et al. Dose estimation for atomic bomb survivor studies: its evolution and present status. Radiat Res 2006; 166: 21954.
  • 13
    Pierce DA, Stram DO, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res 1990; 123: 27584.
  • 14
    Yamada M, Wong FL, Fujiwara S, et al. Noncancer disease incidence in atomic bomb survivors, 1958-1998. Radiat Res 2004; 161: 62232.
  • 15
    Preston DL, Lubin JH, Pierce DA, et al. Epicure users guide. Seattle, WA: Hirosoft International Corporation, 1993.
  • 16
    Lunn DJ, Thomas A, Best N, et al. WinBUGS—a Bayesian modelling framework: concepts, structure, and extensibility. Stat Comput 2000; 10: 32537.
  • 17
    Brenner AV, Tronko MD, Hatch M, et al. I-131 dose response for incident thyroid cancers in Ukraine related to the Chornobyl accident. Environ Health Perspect 2011; 119: 9339.
  • 18
    Zablotska LB, Ron E, Rozhko AV, et al. Thyroid cancer risk in Belarus among children and adolescents exposed to radioiodine after the Chornobyl accident. Br J Cancer 2011; 104: 1817.
  • 19
    Boice JD, Jr. Thyroid disease 60 years after Hiroshima and 20 years after Chernobyl. JAMA 2006; 295: 10602.
  • 20
    Kesminiene A, Evrard A, Ivanov V, et al. Risk of thyroid cancer among Chernobyl liquidators. Third European IRPA Congress 2010: S019.
  • 21
    Richardson DB. Exposure to ionizing radiation in adulthood and thyroid cancer incidence. Epidemiology 2009; 20: 1817.
  • 22
    National Council on Radiation Protection and Measurements, Ionizing Radiation Exposure of the Population of the United States. NCRP Report No. 160. Bethesda, MD, 2009.